Semaglutide is a GLP-1 receptor agonist FDA-approved for chronic weight management in adults with obesity (BMI ≥ 30) or overweight (BMI ≥ 27) with a qualifying comorbidity. Residents of Southeast, Texas can access licensed Semaglutide prescriptions through telehealth — no in-person clinic visit required under Texas Occupations Code §111.001. Board-certified physicians review patient health assessments online and issue prescriptions within 24–48 hours. Compounded Semaglutide from an FDA-registered 503B outsourcing pharmacy ships overnight directly to your Austin address. Monthly cost: $199–$379 — vs. $1,247 for brand-name Ozempic or Wegovy. All prescribing physicians serving Southeast patients are licensed in Texas and regulated by the Texas Medical Board. Medical Director: Dr. Sarah Chen, MD, Board-Certified Internal Medicine. Serving Austin ZIP codes: 78701, 78702, 78703, 78704, 78705.
Local clinics serving Southeast: Texas Weight Loss - South Austin, Blue Tree Health - Medical Weight Loss and Bio-X Weight Loss Center (Austin). Many patients compare these in-person options against licensed Semaglutide telehealth — prescribed online, shipped to the door.
Weight-Loss Injections seen from Southeast, without the jargon. This page is a starting point for comparing the injectable options available via telehealth before a medical evaluation.
Beyond the sticker price, look at what is included: consultation, titration, refills, and shipping are sometimes bundled into a single monthly fee. The monthly cost depends mostly on the format you choose: the brand-name version without insurance is by far the most expensive, while compounded telehealth formulas cut the bill sharply.
Typical dosing: depends on the molecule chosen (semaglutide or tirzepatide) after evaluation. On the cost side, expect about $200-600/month depending on the molecule and format (compounded vs brand). depending on the format (brand vs compounded). Associated brands include Wegovy, Zepbound, Ozempic, Mounjaro. In this state, Texas Occupations Code §111.001; the reference body is Texas Medical Board.
Coverage varies by plan and indication; many patients without coverage opt for a compounded formula at a fixed monthly cost.
The approved molecules (semaglutide, tirzepatide) have a documented safety profile under medical supervision; they require a prescription and monitoring.
The two main ones are semaglutide (GLP-1) and tirzepatide (dual GIP/GLP-1). Tirzepatide shows higher average loss in trials, but the choice depends on tolerance and cost.
Medical Director: Dr. Sarah Chen, MD, Board-Certified Internal Medicine. Licensed in Texas. All prescriptions issued under Texas Occupations Code §111.001 and supervised by Texas Medical Board.